JHS Svendgaard Laboratories Ratios

JHS Svendgaard Laboratories Ltd Ratios

The JHS Svendgaard Laboratories Ltd Ratios page provides a complete fundamental analysis of JHS Svendgaard Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking JHS Svendgaard Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

JHS Svendgaard Laboratories Ltd (NSE: JHS, BSE: 532771) is currently trading at ₹9.11, with a market capitalization of ₹780.71M. As a major player in the Consumer non-durables sector and Household/Personal care industry, JHS Svendgaard Laboratories Ltd remains a key stock for fundamental analysis using JHS Svendgaard Laboratories Ltd Ratios.

JHS Svendgaard Laboratories Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The JHS Svendgaard Laboratories Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in JHS Svendgaard Laboratories Ltd Ratios.

Historically, the JHS Svendgaard Laboratories Ltd P/E ratio has shown strong fluctuations:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0
• 2020: 102.62

The decline in JHS Svendgaard Laboratories Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The JHS Svendgaard Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.55.

Historical P/B trend:

• 2024: 0.55
• 2023: 0.76
• 2022: 0.71
• 2021: 0.72

JHS Svendgaard Laboratories Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The JHS Svendgaard Laboratories Ltd P/S ratio currently stands at 1.01, an important part of JHS Svendgaard Laboratories Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.01
• 2023: 1.81
• 2022: 1.45
• 2021: 1.54

A stable or declining JHS Svendgaard Laboratories Ltd P/S ratio indicates cautious market sentiment.

JHS Svendgaard Laboratories Ltd Price to Cash Flow Ratio (P/CF)

The JHS Svendgaard Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical JHS Svendgaard Laboratories Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 0
• 2022: 5.08
• 2021: 0
• 2020: 10.49

The declining JHS Svendgaard Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

JHS Svendgaard Laboratories Ltd Enterprise Value Ratios

Enterprise Value (EV)

The JHS Svendgaard Laboratories Ltd EV currently stands at ₹798M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 798M
• 2023: 1.23B
• 2022: 870.86M
• 2021: 1.39B

JHS Svendgaard Laboratories Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The JHS Svendgaard Laboratories Ltd EV/EBITDA ratio is currently 0, a key metric in JHS Svendgaard Laboratories Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Stable JHS Svendgaard Laboratories Ltd EV/EBITDA indicates balanced valuation.

JHS Svendgaard Laboratories Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The JHS Svendgaard Laboratories Ltd D/E ratio is currently 0.04, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.04
• 2023: 0.03
• 2022: 0.01
• 2021: 0.03

JHS Svendgaard Laboratories Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The JHS Svendgaard Laboratories Ltd ROE currently stands at -11.53%, showing profitability and capital efficiency.

Historical ROE:

• 2024: -11.53
• 2023: -2.36
• 2022: -9.74
• 2021: -2.16

Declining ROE indicates pressure on profitability.

JHS Svendgaard Laboratories Ltd Ratios Analysis Summary

The JHS Svendgaard Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether JHS Svendgaard Laboratories Ltd stock is undervalued, fairly valued, or overvalued.

Tracking JHS Svendgaard Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.